公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
2016 | Serum biomarkers of VEGF-A and TGF-beta 1 predict pathological response and survival of esophageal cancer patients treated with neoadjuvant chemoradiotherapy and esophagectomy | Cheng, Jason Chia-Hsien; Chiang, Yun; Hsu, Feng-Ming; Tsai, Chiao-Ling; Hsu, Chih-Hung; Lee, Jang-Ming; 成佳憲 | Cancer Immunol. Res. | 0 | 0 | |
2003 | Steroid-Tree Chemotherapy Decreases Hepatitis B Virus (Hbv) Reactivation in Hbv-Carrier Lymphoma Patients | CHENG, ANN-LII; HSIUNG, CHAO A.; SU, IH-JEN; CHEN, PEI-JER; CHANG, MING-CHIH; TSAO, CHAO-JUNG; KAO, WOEI-YAU; UEN, WU-CHING; HSU, CHIH-HUNG; TIEN, HWEI-FANG; CHAO, TSU -YI; CHEN, LI-TZONG; WHANG-PENG, JACQUELINE; 鄭安理; 陳培哲 | HEPATOLOGY | | | |
2016 | The recurrence patterns and post-recurrence survivals in patients with locally advanced esophageal squamous cell carcinoma (ESCC) treated with preoperative paclitaxel/cisplatin-based chemoradiotherapy. | Kuo, Hung-Yang; Guo, Jhe-Cyuan; Huang, Ta-Chen; Lin, Chia-Chi; Hsieh, Min-Shu; Lee, Jang-Ming; Cheng, Jason C.; Wang, Hsiu-Po; Yeh, Kun-Huei; Hsu, Chih-Hung; 成佳憲 | Journal of Clinical Oncology | 0 | 0 | |
2015 | Therapeutic effect of sorafenib is attenuated by tumor-infiltrating Ly6G+myeloid-derived suppressor cells (MDSCs) and is restored by anti-interleukin-6 (IL-6) antibody treatment in an orthotopic mouse liver cancer model | Chang, Chun-Jung; Yang, Yao-Hsu; Chiu, Chiao-Juno; Chiang, Bor-Luen; Lee, Xiao-yi; Hsu, Chih-Hung; Cheng, Ann-Lii; 鄭安理 | Cancer Res. | 0 | 0 | |
2012 | Transforming growth factor-beta mediated epithelial to mesenchymal transition contributes to in vivo resistance to sorafenib in hepatocellular carcinoma | Lin, Shiou-Der; Lin, Tzu-Hsuan; Feng, Wen-Chi; Shao, Yu-Yun; Cheng, Ann-Lii; Hsu, Chih-Hung | Cancer Res. | 0 | 0 | |
2015 | Tumor c-Met expression and prognosis of advanced hepatocellular carcinoma patients treated with sorafenib | Shao, Yu Yun; Hsiao, Chi-Huang; Lee, Ray; Puig, Oscar; Chan, Soa-Yu; Li, Yong-Shi; Hsu, Chih-Hung | Journal of Clinical Oncology | 0 | 1 | |
2013 | Unique histopathologic features of brain metastases from hepatocellular carcinoma | Shao, Yu Yun; Hsieh, Min-Shu; Huang, Chung-Yi; Lu, Li-Chun; Hsu, Chih-Hung; Cheng, Ann-Lii | Journal of Clinical Oncology | 0 | 0 | |
2013 | Vascular endothelial growth factor expression in hepatitis C virus (HCV)-related advanced hepatocellular carcinoma (HCC) compared with hepatitis B virus (HBV)-related advanced HCC | Shao, Yu Yun; Hsieh, Min-Shu; Huang, Chung-Yi; Chang, Yung-Ling; Hsu, Chih-Hung; Cheng, Ann-Lii; 鄭安理 | J. Clin. Oncol. | | | |
2006 | Weekly Cisplatin Plus Infusional High-Dose 5-Fluorouracil and Leucovorin (P-HDFL) for Metastatic Urothelial Carcinoma --- An Effective Regimen with Low Toxicity | Lin, Chia-Chi; Hsu, Chih-Hung; Huang, Chao-Yuan; Cheng, Ann-Lii; Chen, Jun; Vogelzang, Nicholas J.; Pu, Yeong-Shiau | Cancer | | | |
2007 | Weekly paclitaxel and high-dose 5-Fluorouracil plus leucovorin (T-HDFL) in hormone-refractory prostate cancer: in Vitro combined effects and phase II trial | Lin, Chia-Chi; Hsu, Chih-Hung; Hour, Tzyh-Chyuan; Cheng, Ann-Lii; Huang, Chao-Yuan; Huang, Kuo-How; Chen, Jun; Pu, Yeong-Shiau | UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS | | | |
2013 | WNT/beta-catenin signaling inhibitors improve the anti-proliferative effect of sorafenib against hepatocellular carcinoma (HCC) cells. | Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Shao, Yu-Yun; Cheng, Ann-Lii; Hsu, Chih-Hung; 鄭安理 | Cancer Res. | | | |
2013 | WNT/beta-catenin signaling inhibitors improve the anti-proliferative effect of sorafenib against hepatocellular carcinoma (HCC) cells. | Lin, Hsiao-Hui; Feng, Wen-Chi; Lu, Li-Chun; Shao, Yu-Yun; Cheng, Ann-Lii; Hsu, Chih-Hung | Cancer Res. | | | |
2009 | 不同方法之震譜相符強地動歷時對結構地震需求之變異性探討 | 許志鴻; Hsu, Chih-Hung | | | | |
2015 | 投資人參與初次上市(櫃)詢價圈購影響因素之研究 | 許志宏; Hsu, Chih-Hung | | | | |
2006 | 稅負誘發之股權結構移轉與股利偏好探討 | 許志鴻; Hsu, Chih-Hung | | | | |